Central blood pressure is the best predictor of cardiovascular risk.


SphygmoCor® is the industry standard for noninvasive central blood pressure (NcBP) and arterial stiffness - vital data that deliver deep, individual clinical insights.

Learn More
SphygmoCor® XCEL integrates seamlessly into standard clinical workflows. Noninvasive central blood pressure (NcBP) and other unique data can help physicians personalize medications and get patients to goal faster.

Learn More
SphygmoCor® by the numbers

All “Top 20 Hospitals” use SphygmoCor technology to measure central blood pressure (cBP)



1,400+ studies using the SphygmoCor technology have been published in peer-reviewed clinical publications.


8 out of Top 10 Pharma companies have used SphygmoCor technology in their clinical trials



Over 11,000 patients have been tested with SphygmoCor technology in pharmaceutical trials